FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to experimental medicine and ophthalmology, and can be used for treating experimental chemical burns and cataracts modeled on Chinchillas rabbits. That is ensured by instillation of 1–2.5 % (S)-2,6-diaminohexanoic acid solution of 3-methyl-1,2,4-triazolyl-5-thioacetate 3 times a day in burns for 14 days. In cataract eyes are instilled with 1 % solution of (S)-2,6-diaminohexanoic acid 3-methyl-1,2,4-triazolyl-5-thioacetate 3 times day for 28 days.
EFFECT: method provides high therapeutic effect ensured by significant anti-inflammatory, wound-healing, anti-burn, reparative effects of the administered preparation.
1 cl, 3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF EARLY CONSERVATIVE TREATMENT OF MILD AND MODERATE CORNEAL BURNS | 2023 |
|
RU2811887C1 |
| 3-METHYL-1,2,4-TRIAZOLE-5-THIOACETATE (S) -2,6-DIAMINOHEXANE ACID APPLICATION AS ACTIVE DRUG BASE FOR PREVENTION AND TREATMENT OF CNS VITAL FUNCTIONS IN CASE OF SEVERE FORMS OF ACUTE ETHANOL POISONING | 2016 |
|
RU2613875C1 |
| METHOD FOR TREATMENT OF ALCOHOLIC CARDIOMYOPATHY | 2017 |
|
RU2642298C1 |
| METHOD FOR CORRECTING NEUROLOGICAL DISTURBANCES ACCOMPANYING ALCOHOL INTOXICATION | 2014 |
|
RU2561063C1 |
| EYE OINTMENT BASED ON 6-METHYL-3-(THIETAN-3-YL)URACIL WITH WOUND-HEALING EFFECT | 2019 |
|
RU2705392C1 |
| APPLICATION OF L-LYSINE TIAZOTOTATE AS AN ACTIVE BASIS FOR MEDICINES OF HEPATOPROTECTIVE AND DETOXICATIVE ACTION | 2018 |
|
RU2679447C1 |
| OPHTHALMIC DROP | 1999 |
|
RU2163123C2 |
| OPHTHALMIC DROPS | 2002 |
|
RU2216331C1 |
| METHOD OF EYE TREATING BURNS | 2012 |
|
RU2495651C1 |
| METHOD FOR CATARACT TREATMENT AND EYE DROPS FOR IMPLEMENTATION THEREOF | 2016 |
|
RU2662364C2 |
